[News Article]PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer...

14 Jan 2019
Title
PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.
Category
News Article


PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.

(https://bioplus.kr/fairDash.do?hl=ENG)

 

 

For investors attending the BIOPLUS 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management at sungwoo.kim@pharmabcine.com.

 




     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea


     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 


     COPYRIGHT BY PharmAbcine Inc.

     ALL RIGHTS RESERVE